Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1449 | 2658 | 46.9 | 84% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
3 | 4 | PLANT SCIENCES//AGRONOMY//FOOD SCIENCE & TECHNOLOGY | 1882812 |
672 | 3 | GARLIC//HYDROGEN SULFIDE//ALLICIN | 9509 |
2958 | 2 | HYDROGEN SULFIDE//CYSTATHIONINE GAMMA LYASE//GASOTRANSMITTER | 2658 |
1449 | 1 | HYDROGEN SULFIDE//CYSTATHIONINE GAMMA LYASE//GASOTRANSMITTER | 2658 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HYDROGEN SULFIDE | authKW | 4133003 | 40% | 34% | 1050 |
2 | CYSTATHIONINE GAMMA LYASE | authKW | 1203027 | 5% | 78% | 135 |
3 | GASOTRANSMITTER | authKW | 445338 | 3% | 55% | 71 |
4 | HYDROGEN SULPHIDE | authKW | 330542 | 5% | 22% | 128 |
5 | CYSTATHIONINE BETA SYNTHASE | authKW | 270036 | 3% | 28% | 84 |
6 | H2S | authKW | 256943 | 5% | 17% | 134 |
7 | DL PROPARGYLGLYCINE | authKW | 254461 | 1% | 92% | 24 |
8 | HYDROGEN SULFIDE H2S | authKW | 187572 | 1% | 47% | 35 |
9 | H2S DONORS | authKW | 150085 | 1% | 93% | 14 |
10 | CYSTATHIONINE GAMMA LYASE CSE | authKW | 149322 | 0% | 100% | 13 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 1478 | 23% | 0% | 612 |
2 | Physiology | 1299 | 9% | 0% | 226 |
3 | Pharmacology & Pharmacy | 1174 | 15% | 0% | 386 |
4 | Cell Biology | 780 | 11% | 0% | 283 |
5 | Toxicology | 426 | 5% | 0% | 121 |
6 | Medicine, Research & Experimental | 351 | 5% | 0% | 145 |
7 | Endocrinology & Metabolism | 316 | 5% | 0% | 145 |
8 | Peripheral Vascular Diseases | 244 | 4% | 0% | 95 |
9 | Medicine, Legal | 226 | 1% | 0% | 29 |
10 | Neurosciences | 203 | 8% | 0% | 206 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CARDIOVASC BIOL GRP | 143805 | 1% | 52% | 24 |
2 | CARDIOVASC METAB UNIT | 120833 | 1% | 48% | 22 |
3 | OFF VICE P IDENT ECON DEV INNOVAT | 57431 | 0% | 100% | 5 |
4 | MOL IMMUNOL TOXICOL | 54720 | 0% | 53% | 9 |
5 | GP LIVANOS | 47858 | 0% | 83% | 5 |
6 | SHANGHAI BIOACT SMALL MOL | 44819 | 0% | 35% | 11 |
7 | PHARMACOL PATHOPHYSIOL | 36401 | 1% | 11% | 29 |
8 | HUANGPU | 34730 | 0% | 28% | 11 |
9 | NANHUA AFFILIATED HOSP | 31260 | 0% | 39% | 7 |
10 | MOL CARDIOVASC DIS | 29529 | 0% | 43% | 6 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANTIOXIDANTS & REDOX SIGNALING | 26841 | 3% | 3% | 85 |
2 | NITRIC OXIDE-BIOLOGY AND CHEMISTRY | 19367 | 2% | 4% | 48 |
3 | OXIDATIVE MEDICINE AND CELLULAR LONGEVITY | 6069 | 1% | 2% | 30 |
4 | PHARMACOLOGICAL RESEARCH | 2848 | 1% | 1% | 32 |
5 | BRITISH JOURNAL OF PHARMACOLOGY | 1871 | 2% | 0% | 55 |
6 | RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY | 1552 | 1% | 1% | 19 |
7 | PHARMACOLOGICAL REPORTS | 1415 | 1% | 1% | 15 |
8 | FREE RADICAL BIOLOGY AND MEDICINE | 928 | 1% | 0% | 27 |
9 | REDOX BIOLOGY | 861 | 0% | 1% | 6 |
10 | SHOCK | 718 | 1% | 0% | 16 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HYDROGEN SULFIDE | 4133003 | 40% | 34% | 1050 | Search HYDROGEN+SULFIDE | Search HYDROGEN+SULFIDE |
2 | CYSTATHIONINE GAMMA LYASE | 1203027 | 5% | 78% | 135 | Search CYSTATHIONINE+GAMMA+LYASE | Search CYSTATHIONINE+GAMMA+LYASE |
3 | GASOTRANSMITTER | 445338 | 3% | 55% | 71 | Search GASOTRANSMITTER | Search GASOTRANSMITTER |
4 | HYDROGEN SULPHIDE | 330542 | 5% | 22% | 128 | Search HYDROGEN+SULPHIDE | Search HYDROGEN+SULPHIDE |
5 | CYSTATHIONINE BETA SYNTHASE | 270036 | 3% | 28% | 84 | Search CYSTATHIONINE+BETA+SYNTHASE | Search CYSTATHIONINE+BETA+SYNTHASE |
6 | H2S | 256943 | 5% | 17% | 134 | Search H2S | Search H2S |
7 | DL PROPARGYLGLYCINE | 254461 | 1% | 92% | 24 | Search DL+PROPARGYLGLYCINE | Search DL+PROPARGYLGLYCINE |
8 | HYDROGEN SULFIDE H2S | 187572 | 1% | 47% | 35 | Search HYDROGEN+SULFIDE+H2S | Search HYDROGEN+SULFIDE+H2S |
9 | H2S DONORS | 150085 | 1% | 93% | 14 | Search H2S+DONORS | Search H2S+DONORS |
10 | CYSTATHIONINE GAMMA LYASE CSE | 149322 | 0% | 100% | 13 | Search CYSTATHIONINE+GAMMA+LYASE+CSE | Search CYSTATHIONINE+GAMMA+LYASE+CSE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WANG, R , (2012) PHYSIOLOGICAL IMPLICATIONS OF HYDROGEN SULFIDE: A WHIFF EXPLORATION THAT BLOSSOMED.PHYSIOLOGICAL REVIEWS. VOL. 92. ISSUE 2. P. 791 -896 | 356 | 56% | 404 |
2 | WALLACE, JL , WANG, R , (2015) HYDROGEN SULFIDE-BASED THERAPEUTICS: EXPLOITING A UNIQUE BUT UBIQUITOUS GASOTRANSMITTER.NATURE REVIEWS DRUG DISCOVERY. VOL. 14. ISSUE 5. P. 329 -345 | 155 | 86% | 63 |
3 | LI, L , ROSE, P , MOORE, PK , (2011) HYDROGEN SULFIDE AND CELL SIGNALING.ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011. VOL. 51. ISSUE . P. 169 -187 | 104 | 95% | 463 |
4 | LIN, VS , CHEN, W , XIAN, M , CHANG, CJ , (2015) CHEMICAL PROBES FOR MOLECULAR IMAGING AND DETECTION OF HYDROGEN SULFIDE AND REACTIVE SULFUR SPECIES IN BIOLOGICAL SYSTEMS.CHEMICAL SOCIETY REVIEWS. VOL. 44. ISSUE 14. P. 4596 -4618 | 123 | 66% | 101 |
5 | DUNN, WR , ALEXANDER, SPH , RALEVIC, V , ROBERTS, RE , (2016) EFFECTS OF HYDROGEN SULPHIDE IN SMOOTH MUSCLE.PHARMACOLOGY & THERAPEUTICS. VOL. 158. ISSUE . P. 101 -113 | 144 | 94% | 3 |
6 | LIU, YH , LU, M , HU, LF , WONG, PTH , WEBB, GD , BIAN, JS , (2012) HYDROGEN SULFIDE IN THE MAMMALIAN CARDIOVASCULAR SYSTEM.ANTIOXIDANTS & REDOX SIGNALING. VOL. 17. ISSUE 1. P. 141 -185 | 187 | 67% | 76 |
7 | BELTOWSKI, J , (2015) HYDROGEN SULFIDE IN PHARMACOLOGY AND MEDICINE - AN UPDATE.PHARMACOLOGICAL REPORTS. VOL. 67. ISSUE 3. P. 647 -658 | 135 | 85% | 18 |
8 | JIN, Z , CHAN, H , NING, J , LU, K , MA, D , (2015) THE ROLE OF HYDROGEN SULFIDE IN PATHOLOGIES OF THE VITAL ORGANS AND ITS CLINICAL APPLICATION.JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY. VOL. 66. ISSUE 2. P. 169 -179 | 132 | 92% | 6 |
9 | OLSON, KR , (2011) THE THERAPEUTIC POTENTIAL OF HYDROGEN SULFIDE: SEPARATING HYPE FROM HOPE.AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY. VOL. 301. ISSUE 2. P. R297 -R312 | 142 | 80% | 80 |
10 | BOS, EM , VAN GOOR, H , JOLES, JA , WHITEMAN, M , LEUVENINK, HGD , (2015) HYDROGEN SULFIDE: PHYSIOLOGICAL PROPERTIES AND THERAPEUTIC POTENTIAL IN ISCHAEMIA.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 172. ISSUE 6. P. 1479 -1493 | 137 | 86% | 5 |
Classes with closest relation at Level 1 |